These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9692901)

  • 21. Activin A binds to perlecan through its pro-region that has heparin/heparan sulfate binding activity.
    Li S; Shimono C; Norioka N; Nakano I; Okubo T; Yagi Y; Hayashi M; Sato Y; Fujisaki H; Hattori S; Sugiura N; Kimata K; Sekiguchi K
    J Biol Chem; 2010 Nov; 285(47):36645-55. PubMed ID: 20843788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteoglycans of basement membranes.
    Timpl R
    Experientia; 1993 May; 49(5):417-28. PubMed ID: 8500597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.
    Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA
    Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development.
    Abramsson A; Kurup S; Busse M; Yamada S; Lindblom P; Schallmeiner E; Stenzel D; Sauvaget D; Ledin J; Ringvall M; Landegren U; Kjellén L; Bondjers G; Li JP; Lindahl U; Spillmann D; Betsholtz C; Gerhardt H
    Genes Dev; 2007 Feb; 21(3):316-31. PubMed ID: 17289920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of nidogen binding sites for collagen type IV, heparan sulfate proteoglycan, and zinc.
    Reinhardt D; Mann K; Nischt R; Fox JW; Chu ML; Krieg T; Timpl R
    J Biol Chem; 1993 May; 268(15):10881-7. PubMed ID: 8496153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
    Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
    Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding.
    Heidaran MA; Mahadevan D; Larochelle WJ
    FASEB J; 1995 Jan; 9(1):140-5. PubMed ID: 7821753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III.
    Couchman JR; Ljubimov AV; Sthanam M; Horchar T; Hassell JR
    J Histochem Cytochem; 1995 Sep; 43(9):955-63. PubMed ID: 7543915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences.
    Raines EW; Ross R
    J Cell Biol; 1992 Jan; 116(2):533-43. PubMed ID: 1309814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An antibody reactive with domain 4 of the platelet-derived growth factor beta receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization.
    Shulman T; Sauer FG; Jackman RM; Chang CN; Landolfi NF
    J Biol Chem; 1997 Jul; 272(28):17400-4. PubMed ID: 9211881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loop III region of platelet-derived growth factor (PDGF) B-chain mediates binding to PDGF receptors and heparin.
    Schilling D; Reid IV JD; Hujer A; Morgan D; Demoll E; Bummer P; Fenstermaker RA; Kaetzel DM
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):637-44. PubMed ID: 9677323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
    Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
    Hayashi K; Madri JA; Yurchenco PD
    J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of collagens and perlecan in microvascular stability: exploring the mechanism of capillary vessel damage by snake venom metalloproteinases.
    Escalante T; Ortiz N; Rucavado A; Sanchez EF; Richardson M; Fox JW; Gutiérrez JM
    PLoS One; 2011; 6(12):e28017. PubMed ID: 22174764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of mouse and human fibulin-2 to extracellular matrix ligands.
    Sasaki T; Göhring W; Pan TC; Chu ML; Timpl R
    J Mol Biol; 1995 Dec; 254(5):892-9. PubMed ID: 7500359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB).
    Somasundaram R; Schuppan D
    J Biol Chem; 1996 Oct; 271(43):26884-91. PubMed ID: 8900172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin.
    Sasaki T; Hohenester E; Göhring W; Timpl R
    EMBO J; 1998 Mar; 17(6):1625-34. PubMed ID: 9501084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basement membrane composition in the early mouse embryo day 7.
    Gersdorff N; Müller M; Otto S; Poschadel R; Hübner S; Miosge N
    Dev Dyn; 2005 Jul; 233(3):1140-8. PubMed ID: 15895400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
    Doege K; Chen X; Cornuet PK; Hassell J
    Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular interactions in the retinal basement membrane system: a proteomic approach.
    Balasubramani M; Schreiber EM; Candiello J; Balasubramani GK; Kurtz J; Halfter W
    Matrix Biol; 2010 Jul; 29(6):471-83. PubMed ID: 20403434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.